Filter
390
Text search:
tb
coinfection
Featured
38
110
Language
Document type
282
41
34
10
10
5
4
3
1
Countries
18
17
15
14
10
9
8
8
7
7
6
6
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
146
48
6
4
3
3
2
Toolboxes
134
108
14
7
4
3
2
2
1
1
1
1
1
Surveillance Report
Rewiew Article
Hindawi Publishing Corporation, Tuberculosis Research and Treatment; Volume 2011, Article ID 712736, 6 pages, doi:10.1155/2011/712736
Accessed December 2017
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Technical Brief
PLOS ONE | https://doi.org/10.1371/journal.pone.0185526 September 28, 2017
Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisboa, Portugal
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
Towards ending tuberculosis and multidrug-resistant tuberculosis.
4–15 February 2013
Research Article
Received: August 21, 2017; Accepted: August 29, 2017; Published: Spetember 05,
2017
This article is available in: http://www.imedpub.com/advanced-techniques-in-clinical-microbiology/
Technical and operational ‘how-to’: practical considerations
Principes directeurs à l’intention des programmes nationaux et autres partenaires
Série de bulletins techniques
Tuberculose et co-infection par le VIH | 1 - 3
Accessed November 2017
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
J Epidemiol Infect Dis 1(1): 00003.n DOI: 10.15406/jeid.2017.01.00003
Published: September 14, 2017
14–22 April 2015
Report of a mission 20–24 April 2015
10–21 March 2014
Western Pac Surveill Response J. 2014 Oct-Dec; 5(4): 34–46.
Published online 2014 Dec 18. doi: [10.5365/WPSAR.2014.5.4.007]
SARS-CoV-2 infection and pulmonary tuberculosis: analysis of the situation in Peru
MEDICINA (Buenos Aires) 2020; Vol. 80 (Supl. VI): 100-10;
La tuberculosis es una enfermedad infecciosa crónica endémica en la República Argentina causada por Mycobacterium tuberculosis, cuya localización más frecuente es la pulmonar. Suele afectar grupos poblacionales carenciados y tiene gran
...
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
17–24 November 2015
International Journal of Infectious Diseases 46 (2016) 56–60
Version 3.0
Accessed: 24.11.2019
Série de documentos de informação sintéticos do Escritório Regional da OMS para a África sobre a COVID-19 :10.ª série: a COVID-19 e tuberculose
Describir el comportamiento epidemiológico de comorbilidades en
pacientes diagnosticados con tuberculosis de una institución prestadora de servicios
de salud (IPS) de Colombia, durante 2016 a 2019.
A rapid situation analysis in three districts
Policy statement.
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
International Journal of Infectious Diseases 32 (2015) 170–178
http://dx.doi.org/10.1016/j.ijid.2014.11.023
1201-9712/ß 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http:
...
HIV Treatment
Policy Brief
July 2017
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Настоящие руководящие принципы предназначены для специалистов, имеющих дело с теми потребителями наркотиков, которые применяют наиболее проблемные модели потре
...
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Accessed: 26.09.2019
Accessed: 04.10.2019
Accessed: 29.09.2019
Accessed: 27.09.2019
Accessed: 26.09.2019
Accessed: 26.09.2019
Accessed: 24.09.2019
2018 Global HIV Statistics
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
Октябрь 2017
Русский
Рекомендации EACS 9.0
Accessed Febr. 6, 2020
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas
...
The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting of the NSP and the prin
...
Joint actions by the Global Fund and UNAIDS are guided by a strong alignment of strategies, goals and targets. UNAIDS has worked with all stakeholders to set a common agenda and targets within the Global AIDS Strategy 2021–2026, and the United Nations General Assembly confirmed this strategy and i
...
Combined questionnaire Core
Guidelines
HIV drug resistance
July 2017
HIV i-Base
July 2018
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care
...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence
...
Recommendations for a public health approach
2010 revision
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
